|
RAPP Rapport Therapeutics Inc 2012593 |
| Balance Sheet |
|
Current Assets
|
325,939,000 |
|
Assets
|
331,144,000 |
|
Current Liabilities
|
7,099,000 |
|
Liabilities
|
8,030,000 |
|
Equity
|
323,114,000 |
|
Shares Out
|
36,576,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-50,382,000 |
|
Investing Cash Flow
|
-202,071,000 |
| Market Analysis |
Market Cap
|
727,871,341 |
|
Price
|
9.57 |
|
BVPS
|
8.83 |
|
PB
|
1.14 |
|
PS
|
6.63 |
|
FCF
|
-252,453,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view RAPP documents filed with the SEC.
RAPP Filings
Clear
